{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Accelerated degradation",
      "Cold denaturation",
      "Isochoric cooling method",
      "Monoclonal antibody(s)",
      "Protein aggregation",
      "Storage stability"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37832611",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "10",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ejpb.2023.10.009",
      "S0939-6411(23)00269-2"
    ],
    "Journal": {
      "ISSN": "1873-3441",
      "JournalIssue": {
        "Volume": "192",
        "PubDate": {
          "Year": "2023",
          "Month": "Nov"
        }
      },
      "Title": "European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V",
      "ISOAbbreviation": "Eur J Pharm Biopharm"
    },
    "ArticleTitle": "Native and Non-Native aggregation pathways of antibodies anticipated by cold-accelerated studies.",
    "Pagination": {
      "StartPage": "174",
      "EndPage": "184",
      "MedlinePgn": "174-184"
    },
    "Abstract": {
      "AbstractText": [
        "Assessment of cold stability is essential for manufacture and commercialization of biotherapeutics. Storage stability is often estimated by measuring accelerated rates at elevated temperature and using mathematical models (as the Arrhenius equation). Although, this strategy often leads to an underestimation of protein aggregation during storage. In this work, we measured the aggregation rates of two antibodies in a broad temperature range (from 60 \u00b0C to -25 \u00b0C), using an isochoric cooling method to prevent freezing of the formulations below 0 \u00b0C. Both antibodies evidenced increasing aggregation rates when approaching extreme temperatures, because of hot and cold denaturation. This behavior was modelled using Arrhenius and Gibbs-Helmholtz equations, which enabled to deconvolute the contribution of unfolding from the protein association kinetics. This approach made possible to model the aggregation rates at refrigeration temperature (5\u00a0\u00b0C) in a relatively short timeframe (1-2\u00a0weeks) and using standard characterization techniques (SEC-HPLC and DLS)."
      ],
      "CopyrightInformation": "Copyright \u00a9 2023 The Authors. Published by Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "SmartFreeZ, Ed. Inova\u00e7\u00e3o II, Incubadora Taguspark, Porto Salvo, Portugal; CQE, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal. Electronic address: miguelrodrigues@tecnico.ulisboa.pt."
          }
        ],
        "LastName": "Rodrigues",
        "ForeName": "Miguel A",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "SmartFreeZ, Ed. Inova\u00e7\u00e3o II, Incubadora Taguspark, Porto Salvo, Portugal."
          }
        ],
        "LastName": "Duarte",
        "ForeName": "Andreia",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "SmartFreeZ, Ed. Inova\u00e7\u00e3o II, Incubadora Taguspark, Porto Salvo, Portugal; CQE, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisbon, Portugal."
          }
        ],
        "LastName": "Geraldes",
        "ForeName": "Vitor",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biologics Drug Product Development, Sanofi, Framingham, MA, USA."
          }
        ],
        "LastName": "Kingsbury",
        "ForeName": "Jonathan S",
        "Initials": "JS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biologics Drug Product Development, Sanofi, Framingham, MA, USA; Current address: Commercial Drug Product Manufacturing Science and Technology, Moderna, Norwood, MA, USA."
          }
        ],
        "LastName": "Sanket",
        "ForeName": "Patke",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biologics Drug Product Development, Sanofi, Vitry-sur-Seine, France."
          }
        ],
        "LastName": "Filipe",
        "ForeName": "Vasco",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biologics Drug Product Development, Sanofi, Vitry-sur-Seine, France."
          }
        ],
        "LastName": "Nakach",
        "ForeName": "Mostafa",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biologics Drug Product Development, Sanofi, Vitry-sur-Seine, France."
          }
        ],
        "LastName": "Authelin",
        "ForeName": "Jean-Rene",
        "Initials": "JR"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Eur J Pharm Biopharm",
    "NlmUniqueID": "9109778",
    "ISSNLinking": "0939-6411"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Protein Stability"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cold Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Freezing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Denaturation"
    }
  ],
  "CoiStatement": "Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}